ClinicalTrials.Veeva

Menu

Effect of Addition of Dexmedetomidine During Ultrasound Guided Bilateral Single Shot Erector Spinae Plane Block in Patients Undergoing Posterior Lumbar Interbody Fusion Under General Anesthesia

T

Tanta University

Status and phase

Completed
Early Phase 1

Conditions

Posterior Lumbar Interbody Fusion (PLIF)
Lumbar Fixation Surgery
Double Level Lumbar Spondylolisthesis (L3-L5)

Treatments

Drug: Ultrasound Guided Bilateral single shot Erector Spinae Plane Block

Study type

Interventional

Funder types

Other

Identifiers

NCT03746418
tantaESB

Details and patient eligibility

About

Posterior lumbar interbody fusion (PLIF) is the management of choice in double level lumbar (L) spondylolisthesis (L3-L5) after ineffective conservative treatment. We evaluated bilateral ultrasound (US)-guided single shot erector spinae plane (ESP) block at the level of lumbar 3 (L3) vertebra with or without dexmedetomidine (Dex).

Full description

Objectives: Posterior lumbar interbody fusion (PLIF) is the management of choice in double level lumbar (L) spondylolisthesis (L3-L5) after ineffective conservative treatment. We evaluated bilateral ultrasound (US)-guided single shot erector spinae plane (ESP) block at the level of lumbar 3 (L3) vertebra with or without dexmedetomidine (Dex).

Methods: A prospective controlled randomized, double-blind study comparing two groups of patients; each group included 20 patients of double level spondylolisthesis (L3-L5) scheduled for (PLIF) under general anesthesia combined with bilateral US-guided ESP single shot block at (L3). Group I received 20 ml of 0. 25% bupivacaine plus one mL normal saline bilaterally. Group II received 20 ml of 0.25% bupivacaine with supplementation of 1 mL containing 100µg dexmedetomidine bilaterally. Post-Anesthesia Care Unit (PACU) length of stay, the total dose of postoperative analgesics need, postoperative visual analogue score (VAS) at 1h, 6h, 12h, and 24 h after the operation and postoperative complications which related to block or opioids were recorded.

ESP block at combined with (Dex) is a safe, effective block with no complications. Addition of 100µg Dex to preoperative ESP block provided good postoperative opioid-sparing analgesia, facilitated the early emergence and shortened the length of stay in the PACU during (PLIF) for double level spondylolisthesis (L3-L5).

Enrollment

40 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • belonged to the American Society of Anesthesiologists (ASA) physical status I or II
  • either sex
  • aged 18-60 years
  • body mass index less 35 kg/m2
  • complaining from double level lumbar spondylolisthesis (L3-L5)
  • scheduled for elective surgical intervention aimed at lumbar spine fixation by PLIF - under general anesthesia.

Exclusion criteria

  • obesity (body mass index > 35 kg/m2)
  • infection of the skin at the site of the needle puncture
  • allergies to either of the study drugs
  • bleeding disorder
  • and recent use of opioid.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

40 participants in 2 patient groups, including a placebo group

Group I
Placebo Comparator group
Description:
received 20 ml of 0. 25% bupivacaine plus one mL normal saline bilaterally.
Treatment:
Drug: Ultrasound Guided Bilateral single shot Erector Spinae Plane Block
Group II
Active Comparator group
Description:
received 20 ml of 0.25% bupivacaine with supplementation of 1 mL containing 100µg dexmedetomidine bilaterally
Treatment:
Drug: Ultrasound Guided Bilateral single shot Erector Spinae Plane Block

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems